Astellas Pharma Global Development Inc

We track 3 ClinicalTrials.gov studies led by Astellas Pharma Global Development Inc. The portfolio skews toward Phase 1 (2 trials).

3 clinical trials sponsored by Astellas Pharma Global Development Inc.

Pipeline by Phase

PhaseTrialsDistribution
Phase 1 2
67%
Phase 2 1
33%

Trial Status Breakdown

Trials by Astellas Pharma Global Development Inc

A Phase 1b/2 Study of ASP2998 as Monotherapy and in Combination With Standard Therapies in Participants With Locally Advanced Unresectable or Metastatic Solid Tumors

NCT07287995 · RECRUITING · Phase 2

A Phase 1b Study of Gilteritinib in Participants With Locally Advanced or Metastatic NSCLC With ALK Rearrangement After Prior Treatment With an ALK Inhibitor

NCT07140016 · RECRUITING · Phase 1

A Phase 1 Combined Single and Multiple Ascending Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Food Effect and Biomarker Response of ASP5502 in Healthy Adults and Participants With Primary Sjögren's Syndrome

NCT06544642 · TERMINATED · Phase 1

Frequently Asked Questions

How many clinical trials does Astellas Pharma Global Development Inc sponsor?

Astellas Pharma Global Development Inc currently sponsors 3 clinical trials tracked on ReadTheTrial. These span Phase 1, Phase 2.

What conditions does Astellas Pharma Global Development Inc research?

Astellas Pharma Global Development Inc conducts research across multiple therapeutic areas. Browse the trial listings for details.

Is Astellas Pharma Global Development Inc recruiting for clinical trials?

Yes, Astellas Pharma Global Development Inc currently has 2 trials that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.

Explore More